Germany’s Stada is to expand its over-the-counter business after agreeing to buy a portfolio of consumer health products from GlaxoSmithKline. No financial details of the agreement have been ...
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
GSK Consumer’s (GSK’s) Q2FY19 revenue, Ebitda and PAT growth of 14%, 35% and 43% y-o-y, respectively, surpassed estimates. This was the fourth consecutive quarter of strong volume spurt ...
Hosted on MSN25d
Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?GSK) is a British global pharmaceutical and healthcare company that develops and markets a wide range of medicines, vaccines, and consumer health products. The company is a leader in immunology ...
GlaxoSmithKline's COVID-19 products – antibody drug Xevudy and ... rejected a £50 billion approach from Unilever for its consumer health joint venture with Pfizer, which according to Walmsley ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results